V2X showed 60% EPS growth in its most recent report. Revenue gains came in at 1%. V2X holds the No. 33 rank among its peers ...

UBC offers a host of academic accommodations and has a network of alumni happy to share their tried and true strategies for ...

A Relative Strength Rating upgrade for Teva Pharmaceutical ADR shows improving technical performance. Will it continue?

People who have pro-inflammatory diets are up to three times more likely to have moderate-to-severe IBD, according to a new study.

GLP-1RA use, compared with basal insulin and DPP-4i use, was associated with lower risks for IBD and hospitalization in type 2 diabetes.

Inflammatory bowel disease, in which the immune system attacks the gut, is a painful chronic condition that affects three million Americans. Rates of IBD are rising, and there’s currently no cure. IBD ...

The Crohn’s & Colitis Foundation and an international consortium of leading IBD researchers, today announced the launch of the Global IBD Registry (GLIDE), a pioneering initiative designed to securely ...